The CAP-IT Podcast explores advances in cancer prevention and interception through engaging, accessible conversations grounded in patient perspectives. Bringing together researchers, clinicians, patients, and advocates, the series connects cutting-edge science with real-world questions and needs, highlighting why the research matters and its potential impact on the future of cancer prevention and interception.

]]>https://capit.riverside.com/Riverside.fm (https://riverside.com)Fri, 11 Sep 2026 04:19:44 GMTMon, 17 Aug 2026 16:12:54 GMT60CAP-IT DRCC<p>The <b>CAP-IT Podcast</b> explores advances in cancer prevention and interception through engaging, accessible conversations grounded in patient perspectives. Bringing together researchers, clinicians, patients, and advocates, the series connects cutting-edge science with real-world questions and needs, highlighting why the research matters and its potential impact on the future of cancer prevention and interception.</p>episodicCAP-IT DRCCvero.zhang@gmail.comnoIn the first episode of the CAP-IT Podcast, Dr. Margie Clapper, a cancer prevention researcher at Fox Chase Cancer Center, sits down with patient advocate Erica Kirschner of the Li-Fraumeni Syndrome Association for a candid conversation about living with hereditary cancer risk and the promise of cancer prevention and interception. Together, they explore the challenges faced by high-risk individuals, the importance of genetic testing and patient–scientist collaboration, and how CAP-IT research aims to intervene at the earliest stages of cancer development before a tumor can even be detected.

]]>3c256d8e-5f80-44b7-b205-0137ae3d0cc2Mon, 17 Aug 2026 19:02:29 GMT<p>In the first episode of the<a rel="noopener noreferrer nofollow" href="https://ncicapit.org/en/" target="_blank"> CAP-IT</a> Podcast, Dr. Margie Clapper, a cancer prevention researcher at Fox Chase Cancer Center, sits down with patient advocate Erica Kirschner of the <a rel="noopener noreferrer nofollow" href="https://www.lfsassociation.org" target="_blank">Li-Fraumeni Syndrome Association</a> for a candid conversation about living with hereditary cancer risk and the promise of cancer prevention and interception. Together, they explore the challenges faced by high-risk individuals, the importance of genetic testing and patient–scientist collaboration, and how CAP-IT research aims to intervene at the earliest stages of cancer development before a tumor can even be detected.</p>no00:41:5711Intercepting Cancer Before It Starts: A Patient–Scientist Conversationfull